Cannara Biotech Inc.
No trades
Fundamentals and stats
Top segments and regional performance
Last year, the company generated 77.74 M USD, the most of which — 74.95 M USD — came from its top-performing segment, Cannabis, compared to 57.50 M USD the previous year. The greatest contribution came from Canada, which accounted for 74.95 M USD last year, with 57.50 M USD the year before.
By source
By country